Biogen's stock rises 4% after releasing new data on late-stage Alzheimer's drug - CNBC

1. Biogen's stock rises 4% after releasing new data on late-stage Alzheimer's drug  CNBC
2. New details emerge on drug that may slow Alzheimer's disease  NBCNews.com
3. Biogen Stock Pops On New Alzheimer's Treatment Analysis  Investor's Business Daily
4. Biogen Has More Hope Than Data for Alzheimer’s Drug  Bloomberg
5. Data on Biogen's Alzheimer's drug raise more questions than answers  STAT
6. View full coverage on Google News

(CLICK HERE TO READ AND SEE MORE)